Pune, India -- (SBWire) -- 02/09/2018 --Oral Cancer Treatment Market report provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the Oral Cancer Treatment Market. The global oral cancer treatment market is expected to grow at an approximate CAGR of 7.1% during the forecast period.
The Global Oral Cancer Treatment Market is expected to grow at an approximate CAGR of 7.1% during the forecast period. Cancer is defined as the uncontrolled growth of the cells that can invade and damage the surrounding cells. Oral cancer or mouth cancer is a type of cancer that effects the oral cavity. A sore of mouth that is not going away, can be an indication of oral cancer. Various types of oral cancers are inclusive of squamous cell carcinoma, verrucous carcinoma, minor salivary gland carcinomas, lymphomas, and others. However, a majority of the reported cases of oral cancer is restricted to the squamous cell carcinoma. Increasing prevalence of oral cancer, rising per capita healthcare expenditures, and growing awareness about oral diseases are some of the major drivers for the market growth during the forecast period. In 2017, according to the Oral Cancer Foundation, 49,750 Americans are estimated to be diagnosed with the oral oropharyngeal cancer. Moreover, it is estimated that 9,750 deaths will be accounted for the same, killing one patient every 24 hours. Additionally, in 2015, according to the Centres for Disease Control and Prevention, in the U.S., the total healthcare expenditure accounted for 17.8% of the total gross domestic product (GDP), which accounted for USD 3.2 trillion. However, risks of recurrence of cancer even after the treatment and related side effects followed by high cost of treatment are some of the restraints of the market growth. According to the Dharamshila Hospital, India in 2015, the cost of the treatment of the oral cancers can range from USD 2,995 to USD 14,979.
Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/1820 .
Oral Cancer Treatment Market Key Players:
The key players for the global oral cancer treatment market are Bristol-Myers Squibb Company (U.S.), Qilu Pharmaceutical Co., Ltd. (Asia Pacific), Teva Pharmaceutical Industries Ltd. (Isarael), Eli Lilly and Company. (U.S.), F. Hoffmann-La Roche Ltd (Europe), Merck & Co., Inc. (U.S.), Novartis AG (Europe), Pfizer Inc. (U.S.), and others
Oral Cancer Treatment Market Regional Analysis:
America dominates the global oral cancer treatment market owing to the well-developed healthcare sector. Moreover, the presence of the global players like Bristol-Myers Squibb Company and Merck & Co., Inc. within the regional boundaries fuels the market growth.
Europe holds the second largest market for oral cancer treatment, which is followed by Asia Pacific. Huge patient population and a well-developed healthcare infrastructure will drive the market in the Europe. In 2014, according to the Cancer Research U.K, 11,449 new cases of oral cancer were reported which caused 2,386 estimated death within the same year.
Asia Pacific is the fastest growing region for the market due to the presence of developing economies like India and China within the region. This along with favorable government policies, huge patient population and developing healthcare sector will boost the market growth within the region.
The Middle East & Africa has the least share in the global oral cancer treatment market due to presence of poor economies especially in the African region. Majority of the market of Middle & Africa region is held by the Middle East due to a well-developed healthcare sector and huge healthcare expenditure.
Browse Complete Premium 90 Pages Cooked Research Report Enabled with Respective Tables and Figures is Available @ https://www.marketresearchfuture.com/reports/oral-cancer-treatment-market-1820 .
Oral Cancer Treatment Market Segmentation:
The global oral cancer treatment market is segmented on the basis of type, treatment, and end users.
On the basis of type, the market is segmented into squamous cell carcinoma, verrucous carcinoma, minor salivary gland carcinomas, lymphomas, and others.
On the basis of treatment, the market is segmented into surgery, radiotherapy, chemotherapy, and photodynamic therapy (PDT), and others. The surgery segment is sub segmented into tumor resection, glossectomy, laryngectomy, mohs micrographic surgery, and others. The chemotherapy segment is sub segmented into cisplatin, carboplatin, 5-fluorouracil (5-FU), and others.
On the basis of end users, the market is segmented into hospitals & clinics, research organization, academic institutes, and others.
Major TOC Oral Cancer Treatment Market:
1 Introduction
1.1 Definition
1.2 Scope of Study
1.3 Research Objective
1.4 Assumptions & Limitations
1.4.1 Assumptions
1.4.2 Limitations
2 Research Methodology
2.1 Research Process
2.2 Primary Research
2.3 Secondary Research
3 Market Dynamics
3.1 Introduction
3.2 Growth Drivers
3.3 Growth Barriers
3.4 Opportunities
TOC Continued….
Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/1820 .
About Market Research Future
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Top 10 Oral Cancer Treatment Market Players Overwhelming Success and Growth Rate by 2023
Oral Cancer Treatment Market Research Report, By Type (Squamous Cell Carcinoma, Minor Salivary Gland Carcinomas), By Treatment (Surgery, Radiotherapy, Chemotherapy), By End Users (Research Organization, Academic Institutes) - Global Forecast till 2023